• Projects

Project area C:

Host response to RNA virus infection

Principal investigator:

Prof. Dr. Michael Kracht

Rudolf-Buchheim-Institut für Pharmakologie
Justus-Liebig-Universität Gießen
Schubertstraße 81
35392 Gießen

Phone: 0641-99 47600
E-Mail: michael.kracht(at)pharma.med.uni-giessen(dot)de

Research areas: Signal Transduction, Molecular Virology

Based on their cell biological experience, the Kracht group has made a major and systematic effort to determine the entire transcriptomes, proteomes and phospho-, acetyl-, and ubiquityl proteomes of human coronavirus (HCoV) 229E-infected cells at high resolution. These data sets revealed hundreds of new HCoV-229E-regulated cellular genes and proteins and also demonstrated that the HCoV-229E M- and N-proteins are heavily phosphorylated and acetylated. Furthermore, the Kracht group determined the chromatin landscape of HCoV-229E-infected cells and found more than 1000 CoV-regulated enhancers. This comprehensive insight into transcriptional and post-transcriptional mechanisms in response to coronavirus infection offers multiple avenues for further investigation of virus-host interactions at the molecular level.

Project-related publications of the investigator:
  • Weiterer SS, Meier-Soelch J, Georgomanolis T, Mizi A, Beyerlein A, Weiser H, Brant L, Mayr-Buro C, Jurida L, Beuerlein K, Muller H, Weber A, Tenekeci U, Dittrich-Breiholz O, Bartkuhn M, Nist A, Stiewe T, van IWF, Riedlinger T, Schmitz ML, Papantonis A, Kracht M. 2020. Distinct IL-1alpha-responsive enhancers promote acute and coordinated changes in chromatin topology in a hierarchical manner. EMBO J 39:e101533.
  • Kracht M, Muller-Ladner U, Schmitz ML. 2020. Mutual regulation of metabolic processes and proinflammatory NF-kappaB signaling. J Allergy Clin Immunol doi:10.1016/j.jaci.2020.07.027.
  • Weber A, Dam S, Saul VV, Kuznetsova I, Muller C, Fritz-Wolf K, Becker K, Linne U, Gu H, Stokes MP, Pleschka S, Kracht M*, Schmitz ML. 2019. Phosphoproteome Analysis of Cells Infected with Adapted and Nonadapted Influenza A Virus Reveals Novel Pro- and Antiviral Signaling Networks. J Virol 93.*joint last author
  • Mayr-Buro C, Schlereth E, Beuerlein K, Tenekeci U, Meier-Soelch J, Schmitz ML, Kracht M. 2019. Single-Cell Analysis of Multiple Steps of Dynamic NF-kappaB Regulation in Interleukin-1alpha-Triggered Tumor Cells Using Proximity Ligation Assays. Cancers (Basel) 11.
  • Saul VV, Seibert M, Kruger M, Jeratsch S, Kracht M, Schmitz ML. 2019. ULK1/2 Restricts the Formation of Inducible SINT-Speckles, Membraneless Organelles Controlling the Threshold of TBK1 Activation. iScience 19:527-544.
  • Schmitz ML, Shaban MS, Albert BV, Gokcen A, Kracht M. 2018. The Crosstalk of Endoplasmic Reticulum (ER) Stress Pathways with NF-kappaB: Complex Mechanisms Relevant for Cancer, Inflammation and Infection. Biomedicines 6.
  • Poppe M, Wittig S, Jurida L, Bartkuhn M, Wilhelm J, Muller H, Beuerlein K, Karl N, Bhuju S, Ziebuhr J, Schmitz ML, Kracht M. 2017. The NF-kappaB-dependent and -independent transcriptome and chromatin landscapes of human coronavirus 229E-infected cells. PLoS Pathog 13:e1006286.
  • Tenekeci U, Poppe M, Beuerlein K, Buro C, Muller H, Weiser H, Kettner-Buhrow D, Porada K, Newel D, Xu M, Chen ZJ, Busch J, Schmitz ML, Kracht M. 2016. K63-Ubiquitylation and TRAF6 Pathways Regulate Mammalian P-Body Formation and mRNA Decapping. Mol Cell 62:943-957.
Principal investigator:

PD Dr. Chrysanthi Skevaki

Institut für Laboratoriumsmedizin
Philipps-Universität Marburg
35043 Marburg

Phone: 06421-58 63850
E-Mail: chrysanthi.skevaki(at)uk-gm(dot)de

Principal investigator:

Prof. Dr. Harald Renz

Institut für Laboratoriumsmedizin
Philipps-Universität Marburg
35043 Marburg

Phone: 06421-58 66235

Research areas: Molecular Virology, Immunology, Allergy

Respiratory RNA viruses play an important role in the initiation and exacerbation of chronic inflammatory lung disease, including allergic asthma. Clinically relevant pathogens include influenza virus (IAV), rhinovirus (RV), and respiratory syncytial virus (RSV). In the first funding period, the Renz and Skevaki groups focused on the role of IAV infections in the development of allergic asthma, utilizing a well-established murine animal model of experimental asthma. Surprisingly, they found that a single preceding H1N1 IAV infection rendered the mice resistant to subsequent development of allergic airway inflammation, airway hyperresponsiveness and Th2-immune responses. This protection was dependent on the presence of both CD4+ and CD8+ T effector memory cells. By means of comprehensive in silico analyses, ex vivo T-cell peptide stimulation, and in vivo immunization experiments, two MHC-class I H1N1 peptides and two MHC-class II H1N1 peptides, which cross-react with three ovalbumin-derived peptides, were identified. These data illustrate for the first time heterologous immunity of virus-infected animals towards an allergen.

Project-related publications of the investigators:
  • Renz H, Skevaki C. 2020. Early life microbial exposures and allergy risks: opportunities for prevention. Nat Rev Immunol.
  • Skevaki C, Karsonova A, Karaulov A, Xie M, Renz H. 2020. Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol.
  • Skevaki C, Fragkou PC, Cheng C, Xie M, Renz H. 2020. Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus. J Infect 81:205–212.
  • Balz K, Trassl L, Härtel V, Nelson PP, Skevaki C. 2020. Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development. Front Immunol 11:513.
  • Taka S, Nikopoulou C, Polyzos A, Megremis S, Skevaki CL, Roumpedaki E, Trochoutsou A, Thanos D, Papadopoulos NG. Effects of cryopreservation on antiviral responses of primary airway epithelial cells. Allergy. 2019 Dec 27.
  • Matricardi PM, Dramburg S, Potapova E, Skevaki C, Renz H. Molecular diagnosis for allergen immunotherapy. J Allergy Clin Immunol. 2019 Mar;143(3):831-843.
  • Kirjavainen PV, Karvonen AM, Adams RI, Täubel M, Roponen M, Tuoresmäki P, Loss G, Jayaprakash B, Depner M, Ege MJ, Renz H, Pfefferle PI, Schaub B, Lauener R, Hyvärinen A, Knight R, Heederik DJJ, Mutius E von, Pekkanen J. 2019. Farm-like indoor microbiota in non-farm homes protects children from asthma development. Nat Med 25:1089–1095.
  • Potaczek DP, Unger SD, Zhang N, Taka S, Michel S, Akdağ N, Lan F, Helfer M, Hudemann C, Eickmann M, Skevaki C, Megremis S, Sadewasser A, Alashkar Alhamwe B, Alhamdan F, Akdis M, Edwards MR, Johnston SL, Akdis CA, Becker S, Bachert C, Papadopoulos NG, Garn H, Renz H. Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses. J Allergy Clin Immunol. 2018 Aug 14. pii: S0091-6749(18)31139-4.
  • Skevaki C, Hudemann C, Matrosovich M, Möbs C, Paul S, Wachtendorf A, Alashkar Alhamwe B, Potaczek DP, Hagner S, Gemsa D, Garn H, Sette A, Renz H. Influenza-derived peptides cross-react with allergens and provide asthma protection. J Allergy Clin Immunol. 2018 Sep;142(3):804-814.
  • Skevaki C, Renz H. Advances in mechanisms of allergic disease 2017. J Allergy Clin Immunol. 2018 Oct 10. pii: S0091-6749(18)31436-2.
Principal investigator:

Prof. Dr. med. Susanne Herold

Med. Klinik II, Infektiologie
Justus-Liebig-Universität Gießen
Klinikstraße 36
35392 Giessen

Phone: 0641-98 542552
E-Mail: Susanne.Herold(at)innere.med.uni-giessen(dot)de

Research areas: Pneumology, Infectious Diseases, Cell Biology, Molecular Virology

Influenza A virus (IAV) pneumonia is characterized by severe airway and alveolar injury, followed by stem cell-mediated epithelial repair. This project aims at (i) understanding which host signalling pathways at the virus-host interface drive alveolar epithelial cell repair from distinct lung stem cell niches and (ii) elucidating how viral pathogenicity factors impact these mechanisms, resulting in aggravated damage of the distal lung epithelium and in impaired or aberrant repair after IAV-induced pneumonia. In the previous funding period, the Herold group characterized mechanisms that result in impaired alveolar epithelial barrier function after IAV infection in vivo. Particularly, a newly defined pool of local lung epithelial stem/progenitor cells (EpiSPC) was found to be essential for bronchoalveolar tissue regeneration after IAV-induced injury. Their regenerative response depended on cooperation with mesenchymal cells of the stem cell niche and involved a β-catenin/FGF10/FGFR2b signalling axis as well as epithelial GM-CSF. Furthermore, it was demonstrated that IAV infection of the stem cell niche critically impacts the capacity of EpiSPC to mediate coordinated tissue repair. The distinct role and regulation of GM-CSF in EpiSPC-mediated repair as well as the detailed consequences of IAV infection of the stem cell niche with respect to restitutio ad integrum of the injured lung tissue will be elucidated in the 2nd funding period.

Project-related publications of the investigator:
  • Vazquez-Armendariz AI, Heiner M, El Agha E, Salwig I, Hoek A, Hessler MC, Shalashova I, Shrestha A, Carraro G, Mengel JP, Günther A, Morty RE, Vadász I, Schwemmle M, Kummer W, Hain T, Goesmann A, Bellusci S, Seeger W, Braun T, Herold S. 2020. Multilineage murine stem cells generate complex organoids to model distal lung development and disease. The EMBO Journal 39:e103476.
  • Sauerhering L, Kupke A, Meier L, Dietzel E, Hoppe J, Gruber AD, Gattenloehner S, Witte B, Fink L, Hofmann N, Zimmermann T, Goesmann A, Nist A, Stiewe T, Becker S, Herold S, Peteranderl C. 2020. Cyclophilin Inhibitors Restrict Middle East Respiratory Syndrome Coronavirus Via Interferon lambda In Vitro And In Mice. Eur Respir J 56:1901826.
  • Schmoldt C, Vazquez-Armendariz AI, Shalashova I, Selvakumar B, Bremer CM, Peteranderl C, Wasnick R, Witte B, Gattenlohner S, Fink L, Vadasz I, Morty RE, Pleschka S, Seeger W, Gunther A, Herold S. 2019. IRE1 Signaling As a Putative Therapeutic Target in Influenza Virus-induced Pneumonia. Am J Respir Cell Mol Biol 61:537-540.
  • Salwig I, Spitznagel B, Vazquez-Armendariz AI, Khalooghi K, Guenther S, Herold S, Szibor M, Braun T. 2019. Bronchioalveolar stem cells are a main source for regeneration of distal lung epithelia in vivo. EMBO J 38:e102099.
  • Peteranderl C, Kuznetsova I, Schulze J, Hardt M, Lecuona E, Sznajder JI, Vadasz I, Morty RE, Pleschka S, Wolff T, Herold S. 2019. Influenza A Virus Infection Induces Apical Redistribution of Na(+), K(+)-ATPase in Lung Epithelial Cells In Vitro and In Vivo. Am J Respir Cell Mol Biol 61:395-398.
  • Quantius J, Schmoldt C, Vazquez-Armendariz AI, Becker C, El Agha E, Wilhelm J, Morty RE, Vadasz I, Mayer K, Gattenloehner S, Fink L, Matrosovich M, Li XK, Seeger W, Lohmeyer J, Bellusci S, Herold S. 2016. Influenza Virus Infects Epithelial Stem/Progenitor Cells of the Distal Lung: Impact on Fgfr2b-Driven Epithelial Repair. PLoS Pathog 12:e1005544.
  • Peteranderl C, Morales-Nebreda L, Selvakumar B, Lecuona E, Vadasz I, Morty RE, Schmoldt C, Bespalowa J, Wolff T, Pleschka S, Mayer K, Gattenloehner S, Fink L, Lohmeyer J, Seeger W, Sznajder JI, Mutlu GM, Budinger GR, Herold S. 2016. Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection. J Clin Invest 126:1566-80.
  • Herold S, Hoegner K, Vadasz I, Gessler T, Wilhelm J, Mayer K, Morty RE, Walmrath HD, Seeger W, Lohmeyer J. 2014. Inhaled granulocyte/macrophage colony-stimulating factor as treatment of pneumonia-associated acute respiratory distress syndrome. Am J Respir Crit Care Med 189:609-11.
  • Unkel B, Hoegner K, Clausen BE, Lewe-Schlosser P, Bodner J, Gattenloehner S, Janssen H, Seeger W, Lohmeyer J, Herold S. 2012. Alveolar epithelial cells orchestrate DC function in murine viral pneumonia. J Clin Invest 122:3652-64.
  • Cakarova L, Marsh LM, Wilhelm J, Mayer K, Grimminger F, Seeger W, Lohmeyer J, Herold S. 2009. Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair. Am J Respir Crit Care Med 180:521-32.